Europe Supports Autoantibodies as Biomarkers for T1D
29. April 2020
An important letter of support is out! Great to see regulators such as EMA support the work of the C-Path Institute, a key partner of JDRF. Islet autoantibodies can now officially be used as biomarkers in the development of T1D.